NEW YORK, Nov. 13, 2024 (GLOBE NEWSWIRE) -- Sparian Biosciences, Inc. (“Sparian”), a clinical-stage CNS-focused biopharmaceutical company, is proud to…
$70,000 Prize fund will reward innovation and research that addresses challenges of land degradation, desertification and drought Submissions will close…
$70,000 Prize fund will reward innovation and research that addresses challenges of land degradation, desertification and drought Submissions will close…
November 09, 2024 10:30 ET | Source: Ultragenyx Pharmaceutical Inc. Phase 1/2 data show improvements across all domains and confirm…
Main Takeaways: Binance Labs has invested in BIO Protocol, a pioneering protocol transforming the way early-stage scientific research is financed and…